Updated Notice of AGM

Summary by AI BETAClose X

Cambridge Nutritional Sciences plc has rescheduled its Annual General Meeting to Wednesday, October 28, 2026, at 2:00 pm, to ensure the statutory 21-day notice period following the release of its annual report for the year ended March 31, 2026. The company's annual report, which includes the full Notice of AGM details on pages 81-87, is available on its website. Formal notices will be dispatched to shareholders shortly.

Disclaimer*

Cambridge Nutritional Sciences PLC
11 September 2026
 

11 September 2026

Cambridge Nutritional Sciences plc

 

(the "Company" or "CNSL")

 

Updated Notice of AGM and Annual Report to 31 March 2026

 

Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, confirms that the Notice of Annual General Meeting ('AGM') has been rescheduled and finalised for the year ended 31 March 2026. The Company's AGM will be held on Wednesday 28 October 2026 at 2.00pm at E-space North, 181 Wisbech, Littleport, Ely, CB6 1RA. This update is to ensure the statutory 21 days’ clear notice between the results/hard copy annual report receipt and AGM is provided.

 

The Annual Report for the year ended 31 March 2026 is available on the Company's website at:

 

https://www.cnsplc.com/financials/  

 

and includes all the Notice of AGM details on pages 81-87. Formal notices will be sent to all shareholders in the next few weeks.

 

 

Contacts: 

Cambridge Nutritional Sciences plc        

www.cnsplc.com

Carolyn Rand, Non-Executive Chair

investors@cnsplc.com

James Cooper, Chief Executive Officer

 

Ajay Patel, Chief Financial Officer

 

 

Cavendish Capital Markets Limited    

 

Tel: 020 7220 0500

Geoff Nash / Edward Whiley / (Corporate Finance)

 

Nigel Birks / Harriet Ward (ECM)

 

 

 

 

 

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings